ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,085
-0,05%
Bitcoin
64 064,68
0,10%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Amarantus Bioscience Holdings Inc (CE) (AMBS)

  7. Amarantus Bioscience Holdings Inc (CE) (AMBS) Actualités

AMBS

Amarantus Bioscience (CE) (AMBS)

Amarantus Bioscience Holdings Inc (CE)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:AMBS
DateHeureSourceTitreSymboleSociété
09/09/202220h20Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
18/04/202222h18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/10/202012h02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
10/07/202021h03InvestorsHub NewsWireTodos Medical Expands Extraction Reagent and ANDiS 350 Extraction Automation Capacity to Support COVID-19 Testing in the USAUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
30/01/202015h42InvestorsHub NewsWireAmarantus Acquires Majority Interest in CBD Wellness Company HemporiUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
10/01/202012h52Edgar (US Regulatory)Withdrawal of Offering Statement Under Regulation a (1-a-w)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/01/202023h13Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/01/202023h06Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
04/12/201914h17InvestorsHub NewsWireAmarantus Sub Elto Pharma Gets Notice of Allowance Covering Use of Eltoprazine Combined with CBD to Treat Parkinson's DiseaseUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
24/10/201915h52InvestorsHub NewsWireAmarantus Enters Into Agreement to License Diverse Therapeutics Portfolio to CBD-focused Emerald Organic ProductsUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
28/05/201915h51InvestorsHub NewsWireAmarantus Engages Evolution Venture Partners to Evaluate Strategic Alternatives for Expansion into the Legal Hemp IndustryUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
07/01/201914h00InvestorsHub NewsWireAmarantus Provides 2019 RoadmapUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
28/11/201813h30InvestorsHub NewsWireCoeptis Pharma Enters into Agreement to Acquire Elto PharmaUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
20/07/201813h31InvestorsHub NewsWireAmarantus Provides Corporate UpdateUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/07/201814h00InvestorsHub NewsWireMANF Therapeutics Announces Positive MANF Pre-Clinical Data in Alpha-Synuclein Model of Parkinson's Disease Published inUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
11/06/201813h00InvestorsHub NewsWireMANF Therapeutics Announces Independent Publication of Positive Data for MANF in Traumatic Brain Injury Animal ModelUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
07/06/201814h17InvestorsHub NewsWireAmarantus Provides Update on Elto Pharma Capital Formation PlanUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
05/06/201814h11InvestorsHub NewsWireMANF Therapeutics Announces Publication of Positive Data for MANF in Stroke Animal Model in AAAS Journal Science AdvancesUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
30/05/201814h00InvestorsHub NewsWireAmarantus Exercises Exclusive Option with Leipzig University for Alzheimer's Blood Diagnostic "LymPro Test 2.0"USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
24/05/201817h00InvestorsHub NewsWireAmarantus to Present at LD Micro and The Reg A ConferenceUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
22/05/201812h00InvestorsHub NewsWireAmarantus Retains Weild & Co. to Advise on JOBS Act FundingUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
21/05/201813h58InvestorsHub NewsWireMANF Therapeutics Announces Publication in Society for Neuroscience eNeuro Journal of Human Ocular Distribution and Animal..USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
11/05/201813h00InvestorsHub NewsWireAmarantus Provides Business OverviewUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
04/05/201814h16InvestorsHub NewsWireAmarantus Enters into Exclusive Option Agreement with Leipzig University to License IP Covering Alzheimer's Blood DiagnosticUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
03/05/201815h15InvestorsHub NewsWireMANF Therapeutics Announces Issuance of Patent in Hong Kong Covering Use of MANF for Treatment of Diabetes and Wolfram's NewUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
01/05/201816h30InvestorsHub NewsWireElto Pharma Receives Notice of Allowance in Canada for Patent Covering Use of Eltoprazine to Treat non-ADHD Cognitive Impairm...USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
30/04/201813h00InvestorsHub NewsWireElto Pharma Appoints Paula Trzepacz, MD as Chief Medical Advisor Ex-Lilly Sr. Medical Fellow in Neurosciences to leadUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
23/04/201814h00InvestorsHub NewsWireCutanogen Appoints Richard Kagan, MD as Chief Medical Advisor Emeritus Chief of Staff of Shriners Burns Hospital - Cincinnati...USOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
16/04/201813h30InvestorsHub NewsWireAmarantus Appoints Michael T. Ropacki, PhD as Chief Medical Advisor for Alzheimer's Blood Diagnostic LymPro Test ProgramUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
09/04/201818h40InvestorsHub NewsWireAmarantus to Present at The Microcap Conference in NYCUSOTC:AMBSAmarantus Bioscience Holdings Inc (CE)
 Showing the most relevant articles for your search:USOTC:AMBS

Dernières Valeurs Consultées

COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
EU
AI
Air Liquide
EU
HO
Thales
EU
RNO
Renault
NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
PX1
CAC 40
EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
EU
BEL20
Bel 20
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
NYSE
NKE
Nike
EU
BN
Danone
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés